Direxion Daily S&P Biotech Bull 3X ETF
LABU
57 hedge funds and large institutions have $20.3M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2023 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 14 closing their positions.
64% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 14
16% more funds holding
Funds holding: 49 → 57 (+8)
0.12% less ownership
Funds ownership: 0.23% → 0.11% (-0.12%)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
42% less call options, than puts
Call options by funds: $10.9M | Put options by funds: $18.7M
60% less capital invested
Capital invested by funds: $50.9M → $20.3M (-$30.6M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
+$2.4M |
| 2 |
VF
Virtu Financial
New York
|
+$2.03M |
| 3 |
JP Morgan Chase
New York
|
+$1.39M |
| 4 |
LWM
LJI Wealth Management
Indianapolis,
Indiana
|
+$346K |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$339K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JF
Jump Financial
Chicago,
Illinois
|
-$6.6M |
| 2 |
HF
HRT Financial
New York
|
-$6.21M |
| 3 |
Jane Street
New York
|
-$4.47M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.3M |
LABU Hedge Fund Activity: Q1 2023 in Review
57 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q1 2023, worth a combined $20.3M — down 60% from $50.9M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new LABU positions and 14 closed out — a net gain of 9 holders — while 10 added to existing stakes and 12 trimmed.
The largest buyer was Squarepoint, opening a new position worth an estimated $2.4M. The largest seller was Jump Financial, cutting an estimated $6.6M.
- 57 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q1 2023, up from 49 in Q4 2022.
- Funds reported $20.3M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q1 2023, down 60% quarter-over-quarter.
- 23 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q1 2023 and 14 closed out, a net change of +9 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q1 2023 was Squarepoint, an estimated $2.4M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q1 2023 was Jump Financial, an estimated $6.6M sold.
Based on aggregated 13F filings for Q1 2023.